Search - tctmd.com

Displaying 241 - 260 of 1537

Sort: Relevancy | Date

News Daily News

ILUMIEN I 发布：OCT 能够影响 PCI 策略

L.A. McKeown

August 17, 2015

News Daily News

ILUMIEN I Published: OCT Can Affect PCI Strategy

L.A. McKeown

August 17, 2015

News Daily News

ILUMIEN I Publicado: La TCO puede Influir en la Estrategia PCI

L.A. McKeown

August 17, 2015

News Daily News

分期 PCI 可能降低多支病变 STEMI 患者死亡率

L.A. McKeown

August 12, 2015

News Daily News

Staged PCI May Lower Mortality in STEMI Patients With Multivessel Disease

L.A. McKeown

August 12, 2015

News Daily News

Las PCI Programadas podrían Reducir la Mortalidad en Pacientes STEMI Con Enfermedad Multivaso

L.A. McKeown

August 12, 2015

News Daily News

Subestudio del COURAGE: La PCI No Ofrece Beneficio Añadido sobre, Solo, el Tratamiento Médico Óptimo, ni en Hombres ni en Mujeres

L.A. McKeown

August 03, 2015

News Daily News

COURAGE 亚组研究：合并 PCI 并不会改善单纯行 OMT 治疗的女性或男性患者的总体疗效

L.A. McKeown

August 03, 2015

News Daily News

COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men

L.A. McKeown

August 03, 2015

News Daily News

在急性心肌梗死患者中，DES相对于BMS的早期生活质量优势在1年时消失

Yael L. Maxwell

July 31, 2015

News Daily News

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

Yael L. Maxwell

July 31, 2015

News Daily News

En Pacientes IAM, la Ventaja Precoz de Calidad de Vida de los SLF sobre los SMD Desaparece el cabo de 1 Año

Yael L. Maxwell

July 31, 2015

News Daily News

斑块消退证据对于联合使用他汀类药物与依泽替米贝的病例提出了支持

L.A. McKeown

July 29, 2015

News Daily News

La Evidencia de la Regresión de la Placa Avala el Uso Combinado de Ezetimibe+Estatinas

L.A. McKeown

July 29, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Daily News

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

L.A. McKeown

July 29, 2015

News Industry News

Essential Medical Inc. Announces Successful Commencement of EU Studies for MANTA™ Large Bore Vascular Closure Device

July 27, 2015

News Daily News

Registry Provides Reassurance About Rotational Atherectomy Pre-PCI

Todd Neale

July 23, 2015

News Industry News

Eagle Pharmaceuticals’ RTU Bivalirudin NDA Accepted for Filing

July 23, 2015

News Daily News

研究阐明了　VA　系统中　PCI　后应激测试的使用情况

L.A. McKeown

July 22, 2015

Advertisement

ILUMIEN I 发布：OCT 能够影响 PCI 策略

ILUMIEN I Published: OCT Can Affect PCI Strategy

ILUMIEN I Publicado: La TCO puede Influir en la Estrategia PCI

分期 PCI 可能降低多支病变 STEMI 患者死亡率

Staged PCI May Lower Mortality in STEMI Patients With Multivessel Disease

Las PCI Programadas podrían Reducir la Mortalidad en Pacientes STEMI Con Enfermedad Multivaso

Subestudio del COURAGE: La PCI No Ofrece Beneficio Añadido sobre, Solo, el Tratamiento Médico Óptimo, ni en Hombres ni en Mujeres

COURAGE 亚组研究：合并 PCI 并不会改善单纯行 OMT 治疗的女性或男性患者的总体疗效

COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men

在急性心肌梗死患者中，DES相对于BMS的早期生活质量优势在1年时消失

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

En Pacientes IAM, la Ventaja Precoz de Calidad de Vida de los SLF sobre los SMD Desaparece el cabo de 1 Año

斑块消退证据对于联合使用他汀类药物与依泽替米贝的病例提出了支持

La Evidencia de la Regresión de la Placa Avala el Uso Combinado de Ezetimibe+Estatinas

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

Essential Medical Inc. Announces Successful Commencement of EU Studies for MANTA™ Large Bore Vascular Closure Device

Registry Provides Reassurance About Rotational Atherectomy Pre-PCI

Eagle Pharmaceuticals’ RTU Bivalirudin NDA Accepted for Filing

研究阐明了　VA　系统中　PCI　后应激测试的使用情况

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content